vs
Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and Dexcom (DXCM). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.3B, roughly 1.7× Dexcom). Dexcom runs the higher net margin — 21.2% vs 5.1%, a 16.1% gap on every dollar of revenue.
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
CSTM vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.3B |
| Net Profit | $112.0M | $267.3M |
| Gross Margin | — | 62.9% |
| Operating Margin | 7.5% | 25.6% |
| Net Margin | 5.1% | 21.2% |
| Revenue YoY | — | 21.6% |
| Net Profit YoY | — | 153.6% |
| EPS (diluted) | $0.79 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $2.2B | $1.3B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.0B | $1.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $994.2M | ||
| Q2 24 | $1.9B | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $112.0M | $267.3M | ||
| Q3 25 | $88.0M | $283.8M | ||
| Q2 25 | $36.0M | $179.8M | ||
| Q1 25 | $37.0M | $105.4M | ||
| Q4 24 | — | $151.7M | ||
| Q3 24 | — | $134.6M | ||
| Q2 24 | $76.0M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 7.5% | 25.6% | ||
| Q3 25 | 5.8% | 20.1% | ||
| Q2 25 | 2.7% | 18.4% | ||
| Q1 25 | 3.1% | 12.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | 5.4% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | 5.1% | 21.2% | ||
| Q3 25 | 4.1% | 23.5% | ||
| Q2 25 | 1.7% | 15.5% | ||
| Q1 25 | 1.9% | 10.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | 3.9% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.79 | $0.67 | ||
| Q3 25 | $0.62 | $0.70 | ||
| Q2 25 | $0.25 | $0.45 | ||
| Q1 25 | $0.26 | $0.27 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | $0.51 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | $917.7M |
| Total DebtLower is stronger | $1.9B | — |
| Stockholders' EquityBook value | $952.0M | $2.7B |
| Total Assets | $5.4B | $6.3B |
| Debt / EquityLower = less leverage | 2.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $120.0M | $917.7M | ||
| Q3 25 | $122.0M | $1.8B | ||
| Q2 25 | $133.0M | $1.2B | ||
| Q1 25 | $118.0M | $904.9M | ||
| Q4 24 | — | $606.1M | ||
| Q3 24 | — | $621.2M | ||
| Q2 24 | — | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $952.0M | $2.7B | ||
| Q3 25 | $845.0M | $2.7B | ||
| Q2 25 | $780.0M | $2.6B | ||
| Q1 25 | $745.0M | $2.3B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $796.0M | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $5.4B | $6.3B | ||
| Q3 25 | $5.4B | $7.5B | ||
| Q2 25 | $5.4B | $7.3B | ||
| Q1 25 | $5.2B | $6.8B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 2.00× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 2.53× | — | ||
| Q1 25 | 2.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $218.0M | — |
| Free Cash FlowOCF − Capex | $109.0M | — |
| FCF MarginFCF / Revenue | 5.0% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 1.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $218.0M | $294.0M | ||
| Q3 25 | $99.0M | $659.9M | ||
| Q2 25 | $114.0M | $303.0M | ||
| Q1 25 | $58.0M | $183.8M | ||
| Q4 24 | — | $301.4M | ||
| Q3 24 | — | $199.5M | ||
| Q2 24 | $138.0M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $109.0M | $192.1M | ||
| Q3 25 | $24.0M | $579.4M | ||
| Q2 25 | $37.0M | $208.9M | ||
| Q1 25 | $-11.0M | $96.8M | ||
| Q4 24 | — | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | $54.0M | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | 15.3% | ||
| Q3 25 | 1.1% | 47.9% | ||
| Q2 25 | 1.8% | 18.1% | ||
| Q1 25 | -0.6% | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | 2.8% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | 8.1% | ||
| Q3 25 | 3.5% | 6.7% | ||
| Q2 25 | 3.7% | 8.1% | ||
| Q1 25 | 3.5% | 8.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | 4.3% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.95× | 1.10× | ||
| Q3 25 | 1.13× | 2.33× | ||
| Q2 25 | 3.17× | 1.69× | ||
| Q1 25 | 1.57× | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | 1.82× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
DXCM
Segment breakdown not available.
